Advances on the Association between Hashimoto's Thyroiditis and Viral Infection
-
摘要: 桥本甲状腺炎(hashimoto thyroiditis,HT)的发病率一直呈上升趋势,中青年女性发病率尤为突出。HT的特征是甲状腺出现大量的淋巴细胞浸润,淋巴滤泡形成、甲状腺滤泡上皮细胞变性,参与此过程的最主要的有Th1型T辅助淋巴细胞、细胞毒性T淋巴细胞、自然杀伤细胞(natural killer cells,NK)、单核细胞、浆细胞。桥本甲状腺炎的发病原因较为复杂,环境因素、遗传因素、免疫紊乱等均与该病的发生有关联。近年来桥本甲状腺炎与病毒感染之间的关系受到研究者们关注,人类细小病毒B19、人疱疹病毒6型(HHV-6)、丙型肝炎(HCV)、EB病毒、单纯疱疹病毒(HSV)、人类获得性免疫缺陷病毒(HIV)等感染可能是桥状腺炎的发病原因之一。现就桥本甲状腺炎发病与病毒感染之间的关系研究进展作综述。Abstract: The incidence of Hashimoto Thyroiditis(HT)has been on the rise, especially in young and middle-aged women. Th1 T helper lymphocytes, cytotoxic T lymphocytes, natural killer cells(NK), monocytes, plasma cells are the most important agents involved in this process. The etiology of Hashimoto thyroiditis is complicated, involving environmental factors, genetic factors and immune disorders, among others. In recent years, the relationship between Hashimoto thyroiditis and viral infection has attracted many researchers. Human parvovirus B19, human herpesvirus 6(HHV-6), hepatitis C(HCV), EB virus, herpes simplex virus(HSV), human acquired immunodeficiency virus(HIV)and other microorganism infections may be the pathogenesis of Hashimoto thyroiditis. This article provides a comprehensive review of relationship between the Hashimoto thyroiditis and viral infection.
-
Key words:
- Hashimoto thyroiditis /
- Viral infection /
- Autoimmune diseases
-
[1] 张敏, 张毅. 益气化痰消瘿法对桥本甲状腺炎患者血清甲状腺球蛋白抗体、甲状腺过氧化物酶抗体的影响[J].中医杂志,2007,48(5):414-415. [2] Vanderpump M P, Tunbridge W M. Epidemiology and prevention of clinical and subclinical hypothyroidism[J]. Thyroid,2002,12(10):839-847. [3] 杜丽坤, 张雯. 从中医角度探析桥本甲状腺炎发生与体质的关系[J].长春中医药大学学报,2015,30(3):441-443. [4] Salzano M,Russo. Postiglione L,et al. Inter-feron-gamma inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells[J]. Endocrinol,2012,215(3):439-444. doi: 10.1530/JOE-12-0335 [5] 张月华. TLR7, 9和人细小病毒B19在桥本甲状腺炎病变甲状腺组织中的相互关系[D]. 西安: 第四军医大学硕士学位论文, 2013. [6] Patiroglu T,Gungor HEUnal E,et al. Hashimoto thyroiditis associated with ataxia telangiectasia[J]. Pediatr Endocrinol Metab,2012,25(3-4):349-352. [7] Pattison J R,Jones S E,Hodgson J,et al. Parvovirus infections and hypoplastic cri-sis in sickle-cell anaemia[J]. Lancet,1981,1(8221):664-665. [8] Kerr J R. Pathogenesis of human parvovirus B19 in rheumatic disease[J]. Ann Rheum Dis,2000,59(9):672-683. doi: 10.1136/ard.59.9.672 [9] Kerr S,OKeeffe G,Kilty C,et al. Undernatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG[J]. J Med Virol,1999,57(2):179-185. doi: 10.1002/(SICI)1096-9071(199902)57:2<179::AID-JMV16>3.0.CO;2-T [10] Heegaard E D,Brown K E. Human parvovirus B19[J]. Clin Microbiol Rev,2002,15(3):485-505. doi: 10.1128/CMR.15.3.485-505.2002 [11] Heegaard E D,Hasle H,Skibsted L,et al. Congenital anaemia by parvoviurs B19 infection[J]. The Lancet,1994,343(8902):895-896. doi: 10.1016/S0140-6736(94)90011-6 [12] 王荣,刘晓玲. Toll样受体与人细小病毒B19在桥本氏甲状腺炎发病机制中联合作用[J].中国现代医生,2015,53(8):157-160. [13] Mori K,Munakata Y,Saito T,et al. Intrathyroidal persis-tence ofhuman parvovirus B19 DNA in a patient with hashimoto's thyroiditis[J]. J Infect,2007,55(5):29-31. [14] Wang J,Zhang W,Liu H,et al. Parvovirus B19 infection associated with hashimoto's thyroiditis in adults[J]. J Infect,2010,60(5):360-370. doi: 10.1016/j.jinf.2010.02.006 [15] Mori K,Munakata Y,Saito T,et al. Intrathyroidal persistence of human parvo-virus B19 DNA in a patient with hashimoto's thyroiditis[J]. Journal of Infection,2007,55(2):e29-e31. doi: 10.1016/j.jinf.2007.05.173 [16] Lehmann H W,Lutterbuse N,Plentz A,et al. Association of parvovirus B19 infection and hashimoto's thyroiditis in children[J]. Viral Immunol,2008,21(3):379-383. doi: 10.1089/vim.2008.0001 [17] Adamson L A,Fowler L J,Clare-Salzler M J,et al. Parvovirus B19 infection in Hashimoto's thyroiditis,papillary thyroid carcinoma and anaplastic thyroid carcinoma[J]. Thyroid,2011,21(4):411-417. doi: 10.1089/thy.2010.0307 [18] 王春红,刘伟,梁立双. 人细小病毒B19与Toll样受体3在桥本氏甲状腺炎发病机制的研究[J].中华医院感染学杂志,2015,25(18):4108-4110. [19] Di Luca D,Dolcetti R,Mirandola P,et al. (1994) Human herpesvirus 6:A survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders[J]. The Journal of Infectious Diseases,1994,170(1):211-215. doi: 10.1093/infdis/170.1.211 [20] Scotet E,Peyrat M A,Saulquin X,et al. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions:towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes[J]. Eur J Immunol,1999,29(3):973-985. doi: 10.1002/(SICI)1521-4141(199903)29:03<973::AID-IMMU973>3.0.CO;2-P [21] Fox R I,Saito I,Chan E K,et al. Viral genomes in lymphomas of patients with Sjögren's Syndrome[J]. Journal of Autoimmunity,1989,2(4):449-455. doi: 10.1016/0896-8411(89)90174-1 [22] Ranger-Rogez S,Vidal E,Liozon F. Denis F. Primary Sjogren's syndrome and antibodies to human herpesvirus type 6[J]. Clin Infect Dis,1994,19(6):1159-1160. doi: 10.1093/clinids/19.6.1159 [23] Rotola A,Merlotti I,Caniatti L,et al. Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease[J]. Mult Scler,2004,10(4):348-354. doi: 10.1191/1352458504ms1045oa [24] Alvarez Lafuente R,Martinez A,Garcia-Montojo M,et al. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur[J]. European Journal of Neurology,2010,17(1):129-135. doi: 10.1111/j.1468-1331.2009.02758.x [25] Challoner P B,Smith K T,Parker J D,et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosi[J]. Proc Natl Acad Sci USA,1995,92(16):7440-7444. doi: 10.1073/pnas.92.16.7440 [26] Potenza L,Luppi M,Barozzi P,et al. HHV-6A in syncytial giant-cell hepatitis[J]. N Engl J Med,2008,359(6):593-602. doi: 10.1056/NEJMoa074479 [27] Caselli E,Zatelli M C,Rizzo R,et al. Virologic and immunologic evidence supporting an association between HHV-6 and hashimoto's thyroiditis[J]. PLOS Pathog,2012,8(10):e100295. [28] Khoury E L,Pereira L. Greenspan F S,et,al. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro[J]. Evidence for a Dual Mechanism of Induction. Am. Pathol,1991,138(5):1209-1223. [29] 刘文恩, 张峥, 谭德明, 等. 慢性丙型肝炎的自身免疫现象中华内科杂志, 2000, 39(8): 563-564. [30] Tomer Y,Blackard J T,Akeno N. Interferon alpha treatment and thyroid dysfunction[J]. Endocrinol Metab Clin North America,2007,36(4):1051-1066. doi: 10.1016/j.ecl.2007.07.001 [31] 徐银,陈奕娟,符和英,等. 宿主遗传因素对丙型肝炎治疗效果影响的研究进展[J].肝脏,2017,22(4):364-367. [32] Tarantino G,Gagliardi G,Conca P. Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist?[J]. Int J Immunopathol Pharmacol,2008,21(2):467-469. doi: 10.1177/039463200802100228 [33] Foldes I,David K,Horvath G,et al. Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha[J]. Orv Hetil,2004,145(23):1211-1216. [34] 马子东,冯鹏,李传杰,等. 丙型肝炎病毒感染与甲状腺疾病相关性分析[J].中华全科医学,2014,14(5):1172-1173. [35] 张方洁,姜崴. 干扰素-α诱发的甲状腺炎的研究进展[J].中华临床医师杂志,2013,19(10):8916-8918. [36] 潘蕾,魏欣,谢玉梅,等. 聚乙二醇干扰素治疗慢性丙型肝炎病毒b乙型肝炎病毒共感染临床疗效[J].临床肝胆病杂志,2011,27(1):85-95. [37] Quaranta J F,Tran A,Regnier D,et al. High prevalence of antibodies to hepatitis C virus (HCV)in patients with anti-thyroid autoantibobies[J]. J Hepatol,1993,18(1):136-138. doi: 10.1016/S0168-8278(05)80022-4 [38] Leri O,Sinopoli M T,Prima M A,et al. Hepatitis C virus antibodies and graves' disease[J]. BMJ,1995,310(6972):128-129. [39] Duclos-Vallee J C,Johanet C,Trinchet J C,et al. High prevalence of serum antibodies to hepatitis C virus patients with Hashimoto's thyroiditis[J]. BrMed,1994,309:846-847. [40] Blackard J T,Kong L,Huber A K,et al. Hepatitis C virus infection of a thyroid cell line:Implications for pathogenesis of hepatitis C virus and thyroiditis[J]. Thyroid,2013,23(7):863-870. doi: 10.1089/thy.2012.0507 [41] 鲁陈,朱颖. 甲状腺自身免疫抗体与丙型肝炎病毒感染的关联性分析[J].实验与检验医学,2017,35(5):757-759. doi: 10.3969/j.issn.1674-1129.2017.05.044 [42] Zohreh J. Autoimmune thyroid disorders in hepatitis C virus infec-tion:Effect of interferon therapy[J]. Indian J Endocrinol Met,2013,17(1):69-75. doi: 10.4103/2230-8210.107856 [43] 王 磊,张立新. α-干扰素治疗丙型肝炎患者甲状腺功能异常及其处理[J].实用肝脏病杂志,2016,19(4):401-403. doi: 10.3969/j.issn.1672-5069.2016.04.005 [44] 冯亚男. EB病毒感染299例临床分析[J].浙江医学,2007,29(12):1277-1279. doi: 10.3969/j.issn.1006-2785.2007.12.013 [45] 张志波. 桥本氏甲状腺炎与EB病毒感染有关[J].中华医学信息导报,中华医学信息导报,1997,11(19):14. [46] Vincenzo Di Crescenz1,Antonio D'Antonio,et al. Human herpes virus associated with hashimoto's thyroiditis[J]. Le Infezioni in Medicinan,2013,21(3):224-225. [47] 于恩庶. 一种人兽共患病——艾滋病[J].中国人兽共患病学报,1987,3(1):53-56. [48] Roos Visser,1 Quirijn de Mast,1 Romana T,et al. Hashimoto's thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus–seropositive patient[J]. Thyriod,2012,8(22):853-855. [49] Medzhitov R,Preston-hurlburt P,Janeway CA JR. A humanhomologue of the drosophila toll protein signals acti- vation of adaptive immunity[J]. Nature,1997,388(6640):394-397. doi: 10.1038/41131 [50] Akira S,Takeda K,Kaisho T. Toll like receptors:Critical proteins linking innate and acquired immunity[J]. Nat Im- munol,2001,2(8):675-680. doi: 10.1038/90609 [51] Drexler S K,Foxwell B M. The role of toll-like receptors in chronicinflammation[J]. Int J Biochem Cell Biol,2010,42(4):506-518. doi: 10.1016/j.biocel.2009.10.009 [52] 王荣. 桥本氏甲状腺炎中TLR9蛋白及人细小病毒B19的表达及临床意义[D]. 太原: 山西医科大学硕士学位论文, 2015. [53] 唐松青, 陈涛涌, 俞宙. RasGRP3通过活化Rap1限制巨噬细胞中TLRs触发的炎症应答[C]. 济南: 全国免疫学学术大会, 2014. [54] Raschi E,Teston i C,Bosisio D,et al. Role of the MyD88 transduction signaling pathway in endothelia l activation by anti-phospholipid antibodies[J]. Blood,2003,101(9):3495-3500. doi: 10.1182/blood-2002-08-2349 [55] Ritossa F M. Experimental activation of specific loci in polytene chromosomes of drosophila[J]. Experimental Cell Research,1964,35(3):601-607. doi: 10.1016/0014-4827(64)90147-8 [56] Antonella Marino Gammazza,Manfredi Rizzo. Roberto Citarrella et al Elevated blood Hsp60,its structural similarities and cross-reactivity with thyroid molecules,and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis[J]. Cell Stress and Chaperones,2014,19(3):343-353. doi: 10.1007/s12192-013-0460-9 [57] T KotanlI,Y Amtake,K Hirai,et al. High expression of heat shock protein 60 in follicular cells of hashimoto's thyroiditis[J]. Auloimmuniiy,1996,25(1):1-8.
点击查看大图
计量
- 文章访问数: 2753
- HTML全文浏览量: 2058
- PDF下载量: 26
- 被引次数: 0